reference/35532417

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35532417

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	796
issn	1442-2042 0919-8172
issueIdentifier	9
pageRange	788-796
publicationName	International journal of urology : official journal of the Japanese Urological Association
startingPage	788
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d4c40cb9f02fd866ab671f3ce45dfa72 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_db82977f82c34ffc18899925584cff1c http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_f72c4a933b191a8bedc88f5ca5aec59f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_f837fa47296b9d06cac3c99084c4d83c
bibliographicCitation	Blas L, Shiota M, Miyake H, Takahashi M, Oya M, Tsuchiya N, Masumori N, Matsuyama H, Obara W, Shinohara N, Fujimoto K, Nozawa M, Ohba K, Ohyama C, Hashine K, Akamatsu S, Kamba T, Mita K, Gotoh M, Tatarano S, Fujisawa M, Tomita Y, Mukai S, Ito K, Tanegashima T, Tokunaga S, Eto M; SNiP-RCC Investigators. Clinical factors for tumor response, progression, and survival in nivolumab for advanced renal cell carcinoma in the SNiP-RCC study. Int J Urol. 2023 Sep;30(9):788–96. doi: 10.1111/iju.15265. PMID: 37528632.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4242-2618 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1507-2464 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_87a03b162b11b996a593a3af8264ee41 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3acbfcf3c7be6c99795c60762b7d601a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_05e4d31abbae066a7ffb5a116be315f0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-6324-0739 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_750e27ff50a198843644793502b2e583 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_76eef0c8608f7c57062837533870dc52 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aec0219f0396e7180d964a1865851fd2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b9b20b1fb693a20a08e4e9641278cf85 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_32fb8f80a05abf486bc276648c711cd0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ae879a108844ff6308b21d6850d3d9fa http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3306-4858 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1394-7506 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b80a076e9cd375075346487452c6f400 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bbc7d9f4bb12ada59f100fbd482133d9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7465-9591 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_81785ccd8a992709f7816593c5c2b61f http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2720-9640 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2841-1998 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dced2d91cc1d739b979454e2f3e4484c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6bac9d6b9b45439a578066d13549aa81 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_399238ed8620764eef435bc5fdf0a84a http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7383-5322 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1678-8619 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e58fda11e0441b97d6fa6ef1848a95e9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-8524-2903
date	202308
identifier	https://pubmed.ncbi.nlm.nih.gov/37528632 https://doi.org/10.1111/iju.15265
isPartOf	https://portal.issn.org/resource/ISSN/0919-8172 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8739 https://portal.issn.org/resource/ISSN/1442-2042
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Clinical factors for tumor response, progression, and survival in nivolumab for advanced renal cell carcinoma in the SNiP‐RCC study
discusses	http://id.nlm.nih.gov/mesh/M0585694 http://id.nlm.nih.gov/mesh/M000675754
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D007680Q000473 http://id.nlm.nih.gov/mesh/D002292Q000473
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D020641 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D000082082Q000627 http://id.nlm.nih.gov/mesh/D000077594Q000009 http://id.nlm.nih.gov/mesh/D008875
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7170 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b83d04d3e3b05ce10d1a5893dc850a9b http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8352 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603

Total number of triples: 67.